We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

A Personalized Microfluidic Model for Kidney Cancer Drug Screening

News   Apr 04, 2019 | Original story from the University of Wisconsin-Madison

 
A Personalized Microfluidic Model for Kidney Cancer Drug Screening

Tumor and normal tissue are removed from the patient during surgery, the cells are isolated, and then injected into the lumen device created by the Beebe lab. There they grew into three-dimensional models of kidney cancer blood vessels. Image credit: University of Wisconsin-Madison

 
 
Advertisement
 

RELATED ARTICLES

Genetically Engineered T Cells a Possible Therapy for Autoimmune Diseases

News

A genetically engineered T cell has been found to effectively target and attack pathogenic cells that cause type one diabetes.

READ MORE

Previously Unknown DNA Modification Discovered in Zebrafish

News

Researchers have now discovered a new form of DNA modification in Zebrafish and the enzyme responsible for this change.

READ MORE

Novel Role of Immune System in Psoriasis

News

Scientists have uncovered another one of the complex immune-mediated mechanisms behind the onset of psoriasis and severe psoriasis lesions. The work highlights potential therapeutic targets for future treatments.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Cell Science Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE